Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|November 17, 2010
Using bioluminescence to monitor treatment response in real time in mice with Mycobacterium ulcerans infectionTianyu Zhang, Si-Yang Li, Paul J Converse, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2020
Telacebec for Ultrashort Treatment of Buruli Ulcer in a Mouse ModelDeepak V Almeida, Paul J Converse, Till F Omansen, et al.
Plos Neglected Tropical Diseases|March 22, 2013
Microbiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans diseaseFred Stephen Sarfo, Paul J Converse, Deepak V Almeida, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2018
Oxazolidinones Can Replace Clarithromycin in Combination with Rifampin in a Mouse Model of Buruli UlcerDeepak V Almeida, Till F Omansen, Si-Yang Li, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2017
Verapamil Increases the Bioavailability and Efficacy of Bedaquiline but Not Clofazimine in a Murine Model of TuberculosisJian Xu, Rokeya Tasneen, Charles A Peloquin, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 7, 2015
Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosisSandeep Tyagi, Nicole C Ammerman, Si-Yang Li, et al.
Mycobacterial Diseases : Tuberculosis & Leprosy|December 20, 2014
Revisiting Anti-tuberculosis Activity of Pyrazinamide in MiceDeepak V Almeida, Sandeep Tyagi, Si-Yang Li, et al.
American Journal of Respiratory and Critical Care Medicine|July 5, 2013
Assessment of clofazimine activity in a second-line regimen for tuberculosis in miceJacques H Grosset, Sandeep Tyagi, Deepak V Almeida, et al.
Plos Neglected Tropical Diseases|January 7, 2014
Accelerated detection of mycolactone production and response to antibiotic treatment in a mouse model of Mycobacterium ulcerans diseasePaul J Converse, Yalan Xing, Ki Hyun Kim, et al.
American Journal of Respiratory and Critical Care Medicine|February 19, 2011
Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient miceMing Zhang, Si-Yang Li, Ian M Rosenthal, et al.
Pageof 4